FDA vaccines chief Vinay Prasad to leave regulator in April - Reuters

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeXgyU28teEVyR0tIazhyWE9KRnpwQ2dQMnJnVWxUY3VhWlVaMjVLdnhxS0RJOVBPSVU1VmNEOVhpZWk5SFloY2NIVlZIUldiWW8wWHpWemMzaXhUQ05mSERPVlZpVWp3bzFvZHBON2lhSkU0N2RTQ3g1el9fOWstNTJXLTA4a1NlOGVqajVBTWFXUEFlR0lKRXA2V3cwc0U2b1ZIUi1pdGFKVkJrMVFYT3NSTlM3MEd1VlJZ?oc=5" target="_blank">FDA vaccines chief Vinay Prasad to leave regulator in April</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

Vinay Prasad, the FDA's top vaccine regulator, is set to leave the agency at the end of April, returning to his academic position at the University of California, San Francisco.

Dr. Vinay Prasad is leaving the FDA for the second time in less than a year, following controversial decisions involving vaccine reviews and specialty drugs for rare diseases.

Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, will depart at the end of April, returning to his academic role at the University of California, San Francisco.

Embattled FDA regulator Vinay Prasad will leave the agency next month, following recent controversies over vaccine approvals and gene therapies.

Dr. Vinay Prasad, head of the FDA's vaccines and biologic medicines division, will leave the agency at the end of April, returning to his academic position at the University of California, San Francisco.